- Home
- NET vs ZTS Comparison
NET vs ZTS Comparison
Compare NET & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NET
- ZTS
- Stock Information
- Founded
- NET 2009
- ZTS 1952
- Country
- NET United States
- ZTS United States
- Employees
- NET N/A
- ZTS N/A
- Industry
- NET Computer Software: Prepackaged Software
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- NET Technology
- ZTS Health Care
- Exchange
- NET Nasdaq
- ZTS Nasdaq
- Market Cap
- NET 59.8B
- ZTS 70.1B
- IPO Year
- NET 2019
- ZTS 2013
- Fundamental
- Price
- NET $152.00
- ZTS $160.64
- Analyst Decision
- NET Buy
- ZTS Strong Buy
- Analyst Count
- NET 26
- ZTS 9
- Target Price
- NET $136.04
- ZTS $217.00
- AVG Volume (30 Days)
- NET 4.8M
- ZTS 3.5M
- Earning Date
- NET 02-06-2025
- ZTS 02-13-2025
- Dividend Yield
- NET N/A
- ZTS N/A
- EPS Growth
- NET N/A
- ZTS 7.89
- EPS
- NET N/A
- ZTS 5.47
- Revenue
- NET $1,669,626,000.00
- ZTS $9,256,000,000.00
- Revenue This Year
- NET $26.44
- ZTS $5.25
- Revenue Next Year
- NET $25.82
- ZTS $6.83
- P/E Ratio
- NET N/A
- ZTS $29.33
- Revenue Growth
- NET 28.76
- ZTS 8.33
- 52 Week Low
- NET $66.24
- ZTS $144.80
- 52 Week High
- NET $177.37
- ZTS $200.53
- Technical
- Relative Strength Index (RSI)
- NET 54.80
- ZTS 37.91
- Support Level
- NET $130.10
- ZTS $154.32
- Resistance Level
- NET $177.37
- ZTS $174.84
- Average True Range (ATR)
- NET 7.27
- ZTS 4.22
- MACD
- NET -1.46
- ZTS -1.67
- Stochastic Oscillator
- NET 46.34
- ZTS 22.42
About NET Cloudflare Inc.
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.